Dicerna Pharmaceuticals
Страна
USA
Краткое название
Dicerna Pharmaceuticals Inc
Штаб квартира
480 Arsenal Street Building 1, Suite 120
Члены правления
Douglas Fambrough, Ph.D., Chief Executive Officer
Bob D. Brown, Ph.D., Chief Scientific Officer
David Cordo, Chief Financial Officer
Chris Cowles, Ph.D., Director, Intellectual Property
David Miller, Ph.D., Senior Director, Business Development
James B. Weissman, Chief Business Officer
Bob D. Brown, Ph.D., Chief Scientific Officer
David Cordo, Chief Financial Officer
Chris Cowles, Ph.D., Director, Intellectual Property
David Miller, Ph.D., Senior Director, Business Development
James B. Weissman, Chief Business Officer
Разделы медицины
Онкология, Терапия
Стадия проекта
Производство
Заболевания
Метаболический синдром
Текущие владельцы
Douglas Fambrough, Ph.D., Chief Executive Officer
Jonathan Fleming, Managing General Partner, Oxford Bioscience Partners
Brian Halak, Ph.D., Partner, Domain Associates
Stephen Hoffman, M.D., Ph.D., Managing Director, Skyline Ventures
Jim Jenson, Ph.D., Dicerna Co-Founder
Dennis Langer, M.D., J.D., Director, Dicerna Pharmaceuticals
Jonathan MacQuitty, Ph.D., Partner, Abingworth
David M. Madden, Chairman, Dicerna Pharmaceuticals
Jonathan Fleming, Managing General Partner, Oxford Bioscience Partners
Brian Halak, Ph.D., Partner, Domain Associates
Stephen Hoffman, M.D., Ph.D., Managing Director, Skyline Ventures
Jim Jenson, Ph.D., Dicerna Co-Founder
Dennis Langer, M.D., J.D., Director, Dicerna Pharmaceuticals
Jonathan MacQuitty, Ph.D., Partner, Abingworth
David M. Madden, Chairman, Dicerna Pharmaceuticals
Технологии
Фармацевтика